Abstract
BackgroundThe cytokine tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown promising anticancer activity in early clinical settings by selectively inducing apoptosis in different tumour types. However, some tumour entities such...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have